Thank you to everyone who made our live session a resounding success!
If you missed the live event on May 6th, or simply want to revisit the presentation, we are excited to announce that the full video recording is now available to watch above.
During the event, TibaRay founders discussed the massive leap forward in clinical performance that TibaRay's technology represents. We laid out exactly how we are building next-generation linear accelerator technology to enable FLASH radiotherapy.
This represents a pivotal moment in both cancer care and the medical technology sector. Our core technology creates a profound paradigm shift by delivering curative doses of radiation in less than a second—freezing organ motion and sparing healthy tissue.
Our Series A funding round is currently underway. You can participate in this investment opportunity right now on Wefunder.
Invest HereWarm regards,
Thinh Tran
CEO, TibaRay, Inc.
Cancer is the leading cause of death worldwide. To change that, radiotherapy must evolve–fast.
Treatments that take minutes allow tumors to shift and patients to move, reducing precision and limiting curative dose.
Normal organs are injured by radiation, forcing clinicians to hold back from the intensity needed for cure.
Most of the world cannot afford enough of today’s machines, leaving millions without lifesaving treatment.
All enabled by our revolutionary Galactica™ linear accelerator platform.
Our core accelerator platform powers breakthroughs across industries.
Commercial agreement validates clinical-market pull and partner confidence.
Portable high-performance imaging development for Government customers.
Novel RF components.
Help us bring FLASH radiotherapy to patients worldwide.
Investment Opportunity
